{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T21:09:45Z","timestamp":1789852185579,"version":"4.0.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,8,15]],"date-time":"2013-08-15T00:00:00Z","timestamp":1376524800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s00277-013-1866-2","type":"journal-article","created":{"date-parts":[[2013,8,14]],"date-time":"2013-08-14T06:18:46Z","timestamp":1376461126000},"page":"255-265","source":"Crossref","is-referenced-by-count":17,"title":["Arsenic trioxide suppressed mantle cell lymphoma by downregulation of cyclin D1"],"prefix":"10.1007","volume":"93","author":[{"given":"Rico K. H.","family":"Lo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yok-Lam","family":"Kwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,15]]},"reference":[{"key":"1866_CR1","unstructured":"Swerdlow SH, Campo E, Seto M, M\u00fcller-Hermelink HK (2008) Mantle cell lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds) WHO classification of tumours of haematopoietic and lymphoid tissues. International Agency for Research on Cancer, Lyon, pp 229\u2013232"},{"issue":"11","key":"1866_CR2","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","volume":"89","author":"The Non-Hodgkin's Lymphoma Classification Project","year":"1997","unstructured":"The Non-Hodgkin's Lymphoma Classification Project (1997) A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 89(11):3909\u20133918","journal-title":"Blood"},{"issue":"4656","key":"1866_CR3","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1126\/science.6610211","volume":"224","author":"Y Tsujimoto","year":"1984","unstructured":"Tsujimoto Y, Yunis J, Onorato-Showe L, Erikson J, Nowell PC, Croce CM (1984) Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation. Science 224(4656):1403\u20131406","journal-title":"Science"},{"issue":"6017","key":"1866_CR4","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/315340a0","volume":"315","author":"Y Tsujimoto","year":"1985","unstructured":"Tsujimoto Y, Jaffe E, Cossman J, Gorham J, Nowell PC, Croce CM (1985) Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11;14) chromosome translocation. Nature 315(6017):340\u2013343","journal-title":"Nature"},{"issue":"5293","key":"1866_CR5","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1126\/science.274.5293.1672","volume":"274","author":"CJ Sherr","year":"1996","unstructured":"Sherr CJ (1996) Cancer cell cycles. Science 274(5293):1672\u20131677","journal-title":"Science"},{"issue":"1","key":"1866_CR6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood-2010-04-189977","volume":"117","author":"P P\u00e9rez-Gal\u00e1n","year":"2011","unstructured":"P\u00e9rez-Gal\u00e1n P, Dreyling M, Wiestner A (2011) Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era. Blood 117(1):26\u201338","journal-title":"Blood"},{"issue":"49","key":"1866_CR7","doi-asserted-by":"crossref","first-page":"7545","DOI":"10.1038\/sj.onc.1205907","volume":"21","author":"Y Guo","year":"2002","unstructured":"Guo Y, Stacey DW, Hitomi M (2002) Post-transcriptional regulation of cyclin D1 expression during G2 phase. Oncogene 21(49):7545\u20137556","journal-title":"Oncogene"},{"issue":"16","key":"1866_CR8","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1038\/sj.onc.1208326","volume":"24","author":"Y Guo","year":"2005","unstructured":"Guo Y, Yang K, Harwalkar J, Nye JM, Mason DR, Garrett MD, Hitomi M, Stacey DW (2005) Phosphorylation of cyclin D1 at Thr 286 during S phase leads to its proteasomal degradation and allows efficient DNA synthesis. Oncogene 24(16):2599\u20132612","journal-title":"Oncogene"},{"issue":"8","key":"1866_CR9","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1101\/gad.11.8.957","volume":"11","author":"JA Diehl","year":"1997","unstructured":"Diehl JA, Zindy F, Sherr CJ (1997) Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev 11(8):957\u2013972","journal-title":"Genes Dev"},{"issue":"22","key":"1866_CR10","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1101\/gad.12.22.3499","volume":"12","author":"JA Diehl","year":"1998","unstructured":"Diehl JA, Cheng M, Roussel MF, Sherr CJ (1998) Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12(22):3499\u20133511","journal-title":"Genes Dev"},{"issue":"24","key":"1866_CR11","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1101\/gad.854900","volume":"14","author":"JR Alt","year":"2000","unstructured":"Alt JR, Cleveland JL, Hannink M, Diehl JA (2000) Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation. Genes Dev 14(24):3102\u20133114","journal-title":"Genes Dev"},{"issue":"40","key":"1866_CR12","doi-asserted-by":"crossref","first-page":"33945","DOI":"10.1074\/jbc.M506206200","volume":"280","author":"YT Kwak","year":"2005","unstructured":"Kwak YT, Li R, Becerra CR, Tripathy D, Frenkel EP, Verma UN (2005) IkappaB kinase alpha regulates subcellular distribution and turnover of cyclin D1 by phosphorylation. J Biol Chem 280(40):33945\u201333952","journal-title":"J Biol Chem"},{"issue":"25","key":"1866_CR13","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1182\/blood-2009-07-216457","volume":"114","author":"MS Tallman","year":"2009","unstructured":"Tallman MS, Altman JK (2009) How I treat acute promyelocytic leukemia. Blood 114(25):5126\u20135135","journal-title":"Blood"},{"issue":"24","key":"1866_CR14","doi-asserted-by":"crossref","first-page":"6425","DOI":"10.1182\/blood-2010-11-283598","volume":"117","author":"SJ Chen","year":"2011","unstructured":"Chen SJ, Zhou GB, Zhang XW, Mao JH, de Th\u00e9 H, Chen Z (2011) From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemia. Blood 117(24):6425\u20136437","journal-title":"Blood"},{"issue":"11","key":"1866_CR15","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00277-002-0552-6","volume":"81","author":"WY Au","year":"2002","unstructured":"Au WY, Ma SK, Chung LP, Chim CS, Kwong YL (2002) Two cases of therapy-related acute promyelocytic leukemia (t-APL) after mantle cell lymphoma and gestational trophoblastic disease. Ann Hematol 81(11):659\u2013661","journal-title":"Ann Hematol"},{"issue":"1","key":"1866_CR16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/hon.870","volume":"27","author":"JE Chang","year":"2009","unstructured":"Chang JE, Voorhees PM, Kolesar JM, Ahuja HG, Sanchez FA, Rodriguez GA, Kim K, Werndli J, Bailey HH, Kahl BS (2009) Phase II study of arsenic trioxide and ascorbic acid for relapsed or refractory lymphoid malignancies: a Wisconsin Oncology Network study. Hematol Oncol 27(1):11\u201316","journal-title":"Hematol Oncol"},{"key":"1866_CR17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0076-6879(05)99006-X","volume":"399","author":"M Fujimuro","year":"2005","unstructured":"Fujimuro M, Yokosawa H (2005) Production of antipolyubiquitin monoclonal antibodies and their use for characterization and isolation of polyubiquitinated proteins. Methods Enzymol 399:75\u201386","journal-title":"Methods Enzymol"},{"issue":"6616","key":"1866_CR18","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/385544a0","volume":"385","author":"A Kauffmann-Zeh","year":"1997","unstructured":"Kauffmann-Zeh A, Rodriguez-Viciana P, Ulrich E, Gilbert C, Coffer P, Downward J, Evan G (1997) Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 385(6616):544\u2013548","journal-title":"Nature"},{"issue":"6559","key":"1866_CR19","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/378785a0","volume":"378","author":"DA Cross","year":"1995","unstructured":"Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378(6559):785\u2013789","journal-title":"Nature"},{"issue":"2","key":"1866_CR20","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/j.1460-2075.1993.tb05715.x","volume":"12","author":"K Hughes","year":"1993","unstructured":"Hughes K, Nikolakaki E, Plyte SE, Totty NF, Woodgett JR (1993) Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation. EMBO J 12(2):803\u2013808","journal-title":"EMBO J"},{"issue":"2","key":"1866_CR21","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1046\/j.1471-4159.1999.0720576.x","volume":"72","author":"M Lesort","year":"1999","unstructured":"Lesort M, Jope RS, Johnson GV (1999) Insulin transiently increases tau phosphorylation: involvement of glycogen synthase kinase-3beta and Fyn tyrosine kinase. J Neurochem 72(2):576\u2013584","journal-title":"J Neurochem"},{"issue":"52","key":"1866_CR22","doi-asserted-by":"crossref","first-page":"52432","DOI":"10.1074\/jbc.M310982200","volume":"278","author":"G Fan","year":"2003","unstructured":"Fan G, Ballou LM, Lin RZ (2003) Phospholipase C-independent activation of glycogen synthase kinase-3beta and C-terminal Src kinase by Galphaq. J Biol Chem 278(52):52432\u201352436","journal-title":"J Biol Chem"},{"issue":"4","key":"1866_CR23","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1091\/mbc.E05-07-0688","volume":"17","author":"CL Sayas","year":"2006","unstructured":"Sayas CL, Ariaens A, Ponsioen B, Moolenaar WH (2006) GSK-3 is activated by the tyrosine kinase Pyk2 during LPA1-mediated neurite retraction. Mol Biol Cell 17(4):1834\u20131844","journal-title":"Mol Biol Cell"},{"issue":"30","key":"1866_CR24","doi-asserted-by":"crossref","first-page":"21395","DOI":"10.1074\/jbc.274.30.21395","volume":"274","author":"JA Hartigan","year":"1999","unstructured":"Hartigan JA, Johnson GV (1999) Transient increases in intracellular calcium result in prolonged site-selective increases in Tau phosphorylation through a glycogen synthase kinase 3beta-dependent pathway. J Biol Chem 274(30):21395\u201321401","journal-title":"J Biol Chem"},{"issue":"10","key":"1866_CR25","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nri1703","volume":"5","author":"M Karin","year":"2005","unstructured":"Karin M, Greten FR (2005) NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5(10):749\u2013759","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"1866_CR26","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1073\/pnas.95.7.3792","volume":"95","author":"L Ling","year":"1998","unstructured":"Ling L, Cao Z, Goeddel DV (1998) NF-kappaB-inducing kinase activates IKK-alpha by phosphorylation of Ser-176. Proc Natl Acad Sci U S A 95(7):3792\u20133797","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6616","key":"1866_CR27","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/385540a0","volume":"385","author":"NL Malinin","year":"1997","unstructured":"Malinin NL, Boldin MP, Kovalenko AV, Wallach D (1997) MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1. Nature 385(6616):540\u2013544","journal-title":"Nature"},{"issue":"24","key":"1866_CR28","doi-asserted-by":"crossref","first-page":"7151","DOI":"10.1093\/emboj\/17.24.7151","volume":"17","author":"A Ciechanover","year":"1998","unstructured":"Ciechanover A (1998) The ubiquitin\u2013proteasome pathway: on protein death and cell life. EMBO J 17(24):7151\u20137160","journal-title":"EMBO J"},{"issue":"3","key":"1866_CR29","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/35056583","volume":"2","author":"L Hicke","year":"2001","unstructured":"Hicke L (2001) Protein regulation by monoubiquitin. Nat Rev Mol Cell Biol 2(3):195\u2013201","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"12","key":"1866_CR30","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/ajh.23317","volume":"87","author":"HJ Jung","year":"2012","unstructured":"Jung HJ, Chen Z, McCarty N (2012) Synergistic anticancer effects of arsenic trioxide with bortezomib in mantle cell lymphoma. Am J Hematol 87(12):1057\u20131064","journal-title":"Am J Hematol"},{"issue":"5975","key":"1866_CR31","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1126\/science.1183424","volume":"328","author":"XW Zhang","year":"2010","unstructured":"Zhang XW, Yan XJ, Zhou ZR, Yang FF, Wu ZY, Sun HB, Liang WX, Song AX, Lallemand-Breitenbach V, Jeanne M, Zhang QY, Yang HY, Huang QH, Zhou GB, Tong JH, Zhang Y, Wu JH, Hu HY, de Th\u00e9 H, Chen SJ, Chen Z (2010) Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML. Science 328(5975):240\u2013243","journal-title":"Science"},{"issue":"12","key":"1866_CR32","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1084\/jem.193.12.1361","volume":"193","author":"V Lallemand-Breitenbach","year":"2001","unstructured":"Lallemand-Breitenbach V, Zhu J, Puvion F, Koken M, Honore N, Doubeikovsky A, Duprez E, Pandolfi PP, Puvion E, Freemont P, de The H (2001) Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML\/retinoic acid receptor alpha degradation. J Exp Med 193(12):1361\u20131371","journal-title":"J Exp Med"},{"issue":"9","key":"1866_CR33","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1182\/blood-2008-06-161000","volume":"112","author":"WY Au","year":"2008","unstructured":"Au WY, Tam S, Fong BM, Kwong YL (2008) Determinants of cerebrospinal fluid arsenic concentration in patients with acute promyelocytic leukemia on oral arsenic trioxide therapy. Blood 112(9):3587\u20133590","journal-title":"Blood"},{"issue":"25","key":"1866_CR34","doi-asserted-by":"crossref","first-page":"6535","DOI":"10.1182\/blood-2011-05-354530","volume":"118","author":"WY Au","year":"2011","unstructured":"Au WY, Kumana CR, Lee HK, Lin SY, Liu H, Yeung DY, Lau JS, Kwong YL (2011) Oral arsenic trioxide-based maintenance regimens for first complete remission of acute promyelocytic leukemia: a 10-year follow-up study. Blood 118(25):6535\u20136543","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-013-1866-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-013-1866-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-013-1866-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T22:55:27Z","timestamp":1596322527000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-013-1866-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,15]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["1866"],"URL":"https:\/\/doi.org\/10.1007\/s00277-013-1866-2","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,15]]}}}